跳到正文
原文
World Health Organization (WHO)· @WHO · X·· 13 天前精选AI 评分58
AI 导读

WHO表示,其专家小组已建议将两款候选疫苗加入刚果(金)正在开展的Tumaini临床试验,以应对由Bundibugyo病毒引起的埃博拉疫情。该疫情已造成超过5000人死亡,WHO正与合作伙伴推进疫苗、治疗和药物的研究。更多信息见 https://bit.ly/4zrtWtn

推荐理由

WHO专家组的推荐使两款候选疫苗进入刚果(金)正在开展的临床试验,读者可据此了解Bundibugyo病毒应对的研发进展。

正文

The ongoing Ebola outbreak caused by the Bundibugyo virus has taken a devastating toll on people’s lives and health, claiming over 5000 lives.

Supporting the Democratic Republic of the Congo’s health response, WHO and partners are working to advance vaccine research, treatments and medicines that can improve care and save lives. WHO expert groups have recommended adding two candidate vaccines to the ongoing Tumaini clinical trial in the DRC, marking a milestone in protecting people against Bundibugyo virus.

Here’s how science is driving the search for solutions in the face of a crisis.

Learn more: https://bit.ly/4zrtWtn

来源:World Health Organization (WHO) · x.com